UBQLN2 and amyotrophic lateral sclerosis: Patient tissue and animal models of UBQLN2-mediated ALS/FTD also demonstrate dendritic spinopathy [39,94], and Ubqln2−/− mice exhibit decreased serotonin receptor positivity in spinal cord and brain sections, further linking changes in protein degradation with neurotransmitter abundance [57].